[Inhibition of thrombocyte adhesiveness in blood by Bencyclan. Experimental and clinical findings].
D001158:Arteries; D001593:Benzyl Compounds / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003508:Cycloheptanes / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005650:Fumarates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D007866:Leg / Q000098:blood supply; D010973:Platelet Adhesiveness / Q000187:drug effects*; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D013927:Thrombosis / Q000188:drug therapy
D001593:Benzyl Compounds; D003508:Cycloheptanes; D005650:Fumarates; D000644:Quaternary Ammonium Compounds
Die Hemmung der Thrombozytenadhäsivität im Nativblut durch Bencyclan. Experimentelle und klinische Ergebnisse.